Aspirin and antiphospholipid syndrome;Aspirine et syndrome des antiphospholipides

Revue de Medecine Interne

Volumn 21, Issue SUPPL. 1, 2000, Pages 83-88

  Hachulla, E ^a   Piette, A M ^b   Hatron, P Y ^a   Bletry O ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Aspirin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; FETUS DEATH; HUMAN; MALE; PREGNANCY; PREGNANCY COMPLICATION; PRIMARY PREVENTION; RECURRENT DISEASE; REVIEW; RISK FACTOR; THROMBOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; FETAL DEATH; FIBRINOLYTIC AGENTS; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS; PRIMARY PREVENTION; RECURRENCE; RISK FACTORS; THROMBOSIS; WARFARIN;

EID: 0034152830     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Harris EN, Baguley L, Asherson A, Hughes GRV. Clinical and serological features of the "antiphospholipid syndrome". Br J Rheumatol 1987 ; 26 Suppl 2 : 19.
2. Asherson RAA. A "primary" antiphospholipid syndrome? J Rheumatol 1988 ; 15 : 1742-6.
3. Cesbron JY, Amoyel P, Masy E. Anticardiolipin antibodies and physical disability in the elderly. Ann Intern Med 1997 ; 126 : 1003.
4. Alarcon-Segovia D, Cabral AR. The antiphospholipid/cofactors syndrome. J Rheumatol 1996 ; 23 : 1319-22.
5. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999 ; 42 : 1309-11.
6. George J, Blank M, Hojnik M, Bar-Meir E, Koike T, Matsuura E, et al. Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). Clin Exp Immunol 1997 ; 108 : 227-33.
7. Roubey AS. Mechanisms of autoantibody-mediated thrombosis. Lupus 1998 ; 7 Suppl 2 : 114-9.
8. Campbell AL, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with antiphospholipid syndrome and with syphilis and platelet activation and aggregation. Thromb Haemostasis 1995 ; 73 : 529-34.
9. Lubbe WF, Liggins GC. Lupus anticoagulant, thrombosis and pregnancy. Am J Obstet Gynecol 1985 ; 153 : 322-7.
10. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstretric complications associated with the lupus anticoagulant. N Engl J Med 1985 ; 313 : 1322-6.
11. Silveira LH, Hubble CL, Jara LJ, Saway S, Martinez-Osuna P, Seleznick MJ, et al. Prevention of anticardiolipin antibody-related pregnancy loss with prednisone and aspirin. Am J Med 1992 ; 93 : 403-11.
12. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989 ; 160 : 439-43.
13. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997 ; 337 : 148-53.
14. Sanchez-Guerrero J, Alarcon-Segovia D. Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during, and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients. J Rheumatol 1992 ; 19 : 1083-8.
15. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993 ; 169 : 1411-7.
16. Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies: A pilot study. Lupus 1993 ; 2 : 319-23.
17. Piette AM, Mourad JJ, Weill B, Thérond P, Grégoire AS, Blétry O. Effect of fish oil derivatives on antiphospholipid antibodies (APL) in 24 patients with the antiphospholipid syndrome (APS). Vth International Conference on SLE, Cancun, Mexico. Lupus 1998 ; 7 Suppl 1 : 49.
18. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 ; 174 : 1584-9.
19. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997 ; 314 : 253-7.
20. Soulier JP, Boffa MC. Avortements à répétition, thromboses et anticoagulant circulant antithromboplastine. Trois observations. Presse Méd 1980 ; 9 : 859-64.
21. Lockshin MD. Pregnancy loss in the antiphospholipid syndrome. Thromb Haemostasis 1999 ; 82 : 641-8.
22. Piette JC. Prevention of recurrent thrombosis in the antiphospholipid syndrome (editorial). Lupus 1994 ; 3 : 73-4.
23. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992 ; 117 : 303-8.
24. Derksen RHWM, De Groot PC, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment. Ann Rheum Dis 1993 ; 52 : 689-92.
25. Vlachoyiannopoulos PC, Tsiakou E, Chalevelakis G, Raptis SA, Moutsopoulos HM. Antiphospholipid syndrome. Clinical and therapeutic aspects. Lupus 1994 ; 3 : 85-90.
26. Rivier G, Herranz MT, Khamashta MA, Hughes GRV. Thrombosis and antiphospholipid syndrome. A preliminary assessment of three antithrombotic treatments. Lupus 1994 ; 3 : 85-90.
27. Shah NM, Khamashta MA, Atsumi T, Hughes GRV. Outcome of patients with anticardiolipin antibodies: a 10-year follow-up of 52 patients. Lupus 1998 ; 7 : 3-6.
28. Khamashta A, Cuadrado MJ. Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995 ; 332 : 993-7.
29. Wahl DG, Guillemin F, de Maistre E, Berret G, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998 ; 7 : 15-22.
30. Whitley LJ, Bertolaccini ML, Katsumata K, Katsumata MA, Hughes GRV. Lupus anticoagulant and antiprothrombin antibodies are a strong marker for thrombosis in patients with autoimmune disease. Arthritis Rheum 1998 ; 41 Suppl : 169.
31. Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies. Medicine 1999 ; 78 : 209-19.
32. Brey RL, Hart RG, Sherman DG, Tegeler CT. Antiphospholipid antibodies and cerebral ischemia in young people. Neurol 1990 ; 40 : 1190-6.
33. Brey RL, Escalante A. Neurological manifestations of antiphospholipid antibody syndrome. Lupus 1998 ; 7 Suppl 2 : 67-74.
34. Levine SR, Brey RL, Joseph CLM, Havstad S. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholpid antibodies. Stroke 1992 ; 23 Suppl : I/29-I/32.
35. Brey RL. Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994 ; 3 : 299-302.
36. Brey RL, Levine SR. Treatment of neurologic complications of antiphospholipid antibody syndrome. Lupus 1996 ; 5 : 473-6.
37. Gomez-Pacheco CL, Villa AR, Drenkard C, Cabiedes J, Cabral AR, Alarcon-Segovia D. Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients. Am J Med 1999 ; 106 : 417-23.
38. Khamashta MA. Management of thrombosis in the antiphospholipid syndrome. Lupus 1996 ; 5 : 463-6.
39. Vaarala O, Mänttäri M, Manninen V, Tenkanen L, Puurunen M, Aho K, et al. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995 ; 91 : 23-7.
40. Nitecki S, Brenner B, Hoffman A, Lanir N, Schramek A, Torem S. Lower-limb ischaemia in primary antiphospholipid syndrome. Eur J Vasc Surg 1993 ; 7 : 414-9.